Clinical Rheumatology

, Volume 28, Issue 3, pp 285–291 | Cite as

Serum levels of tissue inhibitor of metalloproteinase-1 and periarticular bone loss in early rheumatoid arthritis

  • Eithne Murphy
  • Pascale Roux-Lombard
  • Terence Rooney
  • Oliver FitzGerald
  • Jean-Michel Dayer
  • Barry Bresnihan
Original Article


We investigated the relationship between disease activity, serum biological mediators of joint damage, and periarticular bone loss in inflammatory arthritis. Patients with early inflammatory arthritis were recruited from a dedicated early arthritis clinic. At the time of recruitment, all had clinical evidence of synovitis. Patients were assessed at baseline and at 1-year follow-up. Periarticular and axial bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry. Serum levels of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinases 1 (TIMP-1) were measured by enzyme-linked immunosorbent assay. A total 38 patients were included in the study. Twenty had rheumatoid arthritis (RA) and 18 had a seronegative spondylarthropathy (SpA). At baseline, periarticular hand BMD measurements were similar in RA and SpA. At 1 year, the mean periarticular hand BMD was significantly lower in RA (p < 0.05). Significant inverse correlations between both the Ritchie articular index and C-reactive protein levels and the change in periarticular hand BMD at 1 year were observed in RA (r = −0.792, p < 0.001 and r = −0.478, p = 0.045, respectively). Baseline TIMP-1 levels correlated with the change in periarticular hand BMD at 1 year in RA (r = 0.519, p = 0.02). At 1 year, radiographic measures of joint damage were highest in RA. Inverse correlations between the change in periarticular hand BMD and the changes in erosion score (r = −0.90, p = 0.04) were observed in patients demonstrating significant periarticular bone loss. Persistent disease activity was associated with increased periarticular bone loss in the hands in patients with RA, consistent with synovitis-mediated periarticular bone loss. The correlation between baseline TIMP-1 levels and periarticular bone loss over 1 year suggests that TIMP-1 may have utility as a biomarker of periarticular bone loss in early RA.


Bone loss Rheumatoid arthritis TIMP-1 





  1. 1.
    Goldring SR, Gravallese EM (2000) Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthritis Res 2:33–37PubMedCrossRefGoogle Scholar
  2. 2.
    Bywaters EGL (1960) The early radiological signs of rheumatoid arthritis. Bull Rheum Dis 11:231–234PubMedGoogle Scholar
  3. 3.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRefGoogle Scholar
  4. 4.
    Tak PP, Bresnihan B (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 43:2619–2633PubMedCrossRefGoogle Scholar
  5. 5.
    Pap T, Aupperle KR, Gay S, Firestein GS, Gay RE (2001) Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum 44:676–681PubMedCrossRefGoogle Scholar
  6. 6.
    Connell L, McInnes IB (2006) New cytokine targets in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 20:865–878PubMedCrossRefGoogle Scholar
  7. 7.
    Cawston TE, Wilson AJ (2006) Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 20:983–1002PubMedCrossRefGoogle Scholar
  8. 8.
    Cunnane G, FitzGerald O, Beeton C, Cawston TE, Bresnihan B (2001) Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. Arthritis Rheum 44:2263–2274PubMedCrossRefGoogle Scholar
  9. 9.
    Cunnane G, FitzGerald O, Hummel KM, Youssef PP, Gay RE, Gay S, Bresnihan B (2001) Synovial tissue protease gene expression and joint erosions in early rheumatoid arthritis. Arthritis Rheum 44:1744–1753PubMedCrossRefGoogle Scholar
  10. 10.
    Bromley M, Woolley DE (1984) Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint. Arthritis Rheum 27:968–975PubMedCrossRefGoogle Scholar
  11. 11.
    Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943–951PubMedGoogle Scholar
  12. 12.
    Boyce B, Xing L (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther 9(Suppl 1):S1PubMedCrossRefGoogle Scholar
  13. 13.
    Schett G (2007) Erosive arthritis. Arthritis Res Ther 9(Suppl 1):S2PubMedCrossRefGoogle Scholar
  14. 14.
    Taylor WJ, Gladman DD, Helliwell PS et al (2006) Classification criteria for psoriatic arthritis: new criteria from a large international study. Arthritis Rheum 54:2665–2673PubMedCrossRefGoogle Scholar
  15. 15.
    van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRefGoogle Scholar
  16. 16.
    Dougados M, van der Linden S, Juhlin R et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRefGoogle Scholar
  17. 17.
    Ritchie DA et al (1969) Evaluation of a simple articular index for joint tenderness in rheumatoid arthritis. Ann Rheum Dis 28:196PubMedCrossRefGoogle Scholar
  18. 18.
    van der Heijde D (2000) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 27:261–263PubMedGoogle Scholar
  19. 19.
    Murphy E, Bresnihan B, Fitzgerald O (2008) Measurement of periarticular bone mineral density in the hands of patients with early inflammatory arthritis using dual energy X-ray absorptiometry. Clin Rheumatol 27:763–766PubMedCrossRefGoogle Scholar
  20. 20.
    Harrison BJ, Hutchinson CE, Adams J, Bruce IN, Herrick AL (2002) Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 61:1007–1011PubMedCrossRefGoogle Scholar
  21. 21.
    Casteneda S, Gonzalez-Alvaro I, Rodriguez-Salvanes R, Quintana ML, Laffon A, Garcia-Vadillo JA (2007) Reproducibility of metacarpophalangeal bone mass measurements obtained by dual-energy X-ray absorptiometry in healthy volunteers and patients with early arthritis. J Clin Densitometry 10:298–305CrossRefGoogle Scholar
  22. 22.
    Jensen T, Klarlund M, Hansen M, Jensen KE, Podenphant J, Hansen TM, Skjodt H, Hylstrup L (2004) Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital X ray radiogrammetry than dual X ray absorptiometry: relationship with disease activity and radiographic outcome. Ann Rheum Dis 63:15–22PubMedCrossRefGoogle Scholar
  23. 23.
    Jawaid WB, Crosbie D, Shotton J, Reid DM, Stewart A (2006) Use of digital X ray radiogrammetry in the assessment of join damage in rheumatoid arthritis. Ann Rheum Dis 65:459–464PubMedCrossRefGoogle Scholar
  24. 24.
    Manicourt DH, Fujimoto N, Obata K, Thonar EJ (1995) Levels of circulating collagenase, stromelysin-1, and tissue inhibitor on matrix metalloproteinase 1 in patients with rheumatoid arthritis: relationship to serum levels of antigenic keratan sulphate and systemic parameters of inflammation. Arthritis Rheum 38:1031–1039PubMedCrossRefGoogle Scholar
  25. 25.
    Ishiguro N, Ito T, Obata K, Fujimoto N, Iwata H (1996) Determination of stromelysin-1, 72 and 92 kDA type IV collagenase, tissue inhibitor of matrix metalloproteinase 1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 23:1599–1604, (Cunnane 2001)PubMedGoogle Scholar
  26. 26.
    Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, Robins S, Griffiths I (2007) Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. Arthritis Rheum 56:3236–3247PubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2008

Authors and Affiliations

  • Eithne Murphy
    • 1
  • Pascale Roux-Lombard
    • 2
  • Terence Rooney
    • 1
  • Oliver FitzGerald
    • 1
  • Jean-Michel Dayer
    • 2
  • Barry Bresnihan
    • 1
  1. 1.Department of RheumatologySt Vincents University HospitalDublinIreland
  2. 2.Division of Immunology and AllergyUniversity HospitalGenevaSwitzerland

Personalised recommendations